Guinea pig p53 mRNA: Identification of new elements in coding and untranslated regions and their functional and evolutionary implications

Genomics

Volumn 58, Issue 1, 1999, Pages 50-64

  D'Erchia, A M ^a   Pesole, G ^b   Tullo, A ^c   Saccone, C ^a   Sbisa E ^c  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; CONFORMATIONAL TRANSITION; DNA DAMAGE; GENETIC ANALYSIS; GENETIC CODE; GUINEA PIG; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYADENYLATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN STABILITY; RNA TRANSLATION; STRUCTURE ANALYSIS; TRANSLATION REGULATION; TUMOR SUPPRESSOR GENE;

ANIMALIA; CAVIA PORCELLUS; MAMMALIA; RODENTIA; SUS SCROFA; VERTEBRATA;

EID: 0033563148     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1006/geno.1999.5794     Document Type: Article

References (65)

1. Albor A., Laborda J., Notario V. Cloning of the syrian hamster p53 gene: Structural and functional characterization of the upstream promoter region. Mol. Carcinogenesis. 11:1994;176-184.
2. Bayle J. H., Elenbaas B., Levine A. J. The carboxy-terminal domain of the p53 protein regulates sequence-specific DNA binding through its nonspecific nucleic acid-binding activity. Proc. Natl. Acad. Sci. USA. 92:1995;5729-5733.
3. Bienz B., Zakut-Houri R., Givol D., Oren M. Analysis of the gene coding for the murine cellular tumour antigen p53. EMBO J. 3:1984;2179-2183.
4. Bienz-Tadmor B., Zakut-Houri R., Libresco S., Givol D., Oren M. The 5′ region of the p53 gene: Evolutionary conservation and evidence for a negative regulatory element. EMBO J. 4:1985;3209-3213.
5. Cho Y., Gorina S., Jeffrey P. D., Pavletich N. P. Crystal structure of a p53 tumor suppressor-DNA complex: Understanding tumorigenic mutations. Science. 265:1994;346-355.
6. Dang C. V., Lee W. M. Nuclear and nucleolar targeting sequences of c-erb-A, c-myb, N-myc, p53, HSP70, and HIV tat proteins. J. Biol. Chem. 264:1989;18019-18023.
7. D'Erchia A. M., Gissi C., Pesole G., Saccone C., Arnason U. The guinea-pig is not a rodent. Nature. 381:1996;597-600.
8. Frohman M. A. On beyond classic RACE (rapid amplification of cDNA ends). PCR Methods. Appl. 4:1994;S40-S58.
9. Fu L., Minden M. D., Benchimol S. Translational regulation of human p53 gene expression. EMBO J. 15:1996;4392-4401.
10. Fu L., Benchimol S. Participation of the human p53 3′UTR in translational repression and activation following gamma-irradiation. EMBO J. 16:1997;4117-4125.
11. Gebauer F., Richter J. D. Mouse cytoplasmic polyadenylylation element binding protein: An evolutionarily conserved protein that interacts with the cytoplasmic polyadenylylation elements of c-mosmRNA. Proc. Natl. Acad. Sci. USA. 9:1996;14602-14607.
12. Genetics Computer Group (GCG), 1994, 575 Science Drive, Madison, WI.
13. Gouy M., Gautier C., Attimonelli M., Lanave C., di Paola G. ACNUC - A portable retrieval system for nucleic acid sequence databases: Logical and physical designs and usage. CABIOS. 1:1985;167-172.
14. Graur D., Hide W. A., Li W. H. Is the guinea-pig a rodent? Nature. 351:1991;649-652.
15. Gu W., Roeder R. G. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell. 90:1997;595-606.
16. Hainaut P., Hernandez T., Robinson A., Rodriguez-Tome P., Flores T., Hollstein M., Harris C. C., Montesano R. IARC database of p53 gene mutations in human tumors and cell lines: Updated compilation, revised formats and new visualisation tools. Nucleic Acids Res. 26:1998;205-213.
17. Hansen R., Oren M. p53: From inductive signal to cellular effect. Curr. Opin. Genet. Dev. 7:1997;46-51.
18. Ishioka C., Englert C., Winge P., Yan Y. X., Engelstein M., Friend S. H. Mutational analysis of the carboxy-terminal portion of p53 using both yeast and mammalian cell assays in vivo. Oncogene. 10:1995;1485-1492.
19. Jackson R. J., Wickens M. Translational controls impinging on the 5′-untranslated region and initiation factor proteins. Curr. Opin. Genet. Dev. 7:1997;233-241.
20. Jeffrey P. D., Gorina S., Pavletich N. P. Crystal structure of the tetramerization domain of the p53 tumor suppressor at 1.7 angstroms. Science. 267:1995;1498-1502.
21. Jost C. A., Marin M. C., Kaelin W. G. Jr. p73 is a human p53-related protein that can induce apoptosis. Nature. 389:1997;191-194.
22. Jurka J., Zietkiewicz E., Labuda D. Ubiquitous mammalian-wide interspersed repeats (MIRs) are molecular fossils from the mesozoic era. Nucleic Acids Res. 23:1995;170-175.
23. Kaghad M., Bonnet H., Yang A., Creancier L., Biscan J. C., Valent A., Minty A., Chalon P., Lelias J. M., Dumont X., Ferrara P., McKeon F., Caput D. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell. 90:1997;809-819.
24. Ko L. J., Prives C. p53: Puzzle and paradigm. Genes Dev. 10:1996;1054-1072.
25. Kozak M. An analysis of 5′-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res. 15:1987;8125-8148.
26. Kussie P. H., Gorina S., Marechal V., Elenbaas B., Moreau J., Levine A. J., Pavletich N. P. Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain. Science. 274:1996;948-953.
27. Levine A. J. p53, the cellular gatekeeper for growth and division. Cell. 88:1997;323-331.
28. Matlashewski G., Lamb P., Pim D., Peacock J., Crawford L., Benchimol S. Isolation and characterization of a human p53 cDNA clone: Expression of the human p53 gene. EMBO J. 3:1984;3257-3262.
29. McCoy M., Stavridi E. S., Waterman J. L., Wieczorek A. M., Opella S. J., Halazonetis T. D. Hydrophobic side-chain size is a determinant of the three-dimensional structure of the p53 oligomerization domain. EMBO J. 16:1997;6230-6236.
30. Meek D. W., Simon S., Kikkawa U., Eckhart W. The p53 tumour suppressor protein is phosphorylated at serine389 by casein kinase II. EMBO J. 9:1990;3253-3260.
31. Meek D. W., Campbell L. E., Jardine L. J., Knippschild U., McKendrick L., Milne D. M. Multi-site phosphorylation of p53 by protein kinases inducible by p53 and DNA damage. Biochem. Soc. Trans. 25:1997;416-419.
32. Middeler G., Zerf K., Jenovai S., Thulig A., Tschodrich-Rotter M., Kubitscheck U., Peters R. The tumor suppressor p53 is subject to both nuclear import and export, and both are fast, energy-dependent and lectin-inhibited. Oncogene. 14:1997;1407-1417.
33. Milne D. M., Campbell D. G., Caudwell F. B., Meek D. W. Phosphorylation of the tumor suppressor protein p53 by mitogen-activated protein kinases. J. Biol. Chem. 269:1994;9253-9260.
34. Mosner J., Mummenbrauer T., Bauer C., Sczakiel G., Grosse F., Deppert W. Negative feedback regulation of wild-type p53 biosynthesis. EMBO J. 14:1995;4442-4449.
35. Muller-Tiemann B. F., Halazonetis T. D., Elting J. J. Identification of an additional negative regulatory region for p53 sequence-specific DNA binding. Proc. Natl. Acad. Sci. USA. 95:1998;6079-6084.
36. Mummenbrauer T., Janus F., Muller B., Wiesmuller L., Deppert W., Grosse F. p53 protein exhibits 3′-to-5′ exonuclease activity. Cell. 85:1996;1089-1099.
37. Nagaich A. K., Zhurkin V. B., Sakamoto H., Gorin A. A., Clore G. M., Gronenborn A. M., Appella E., Harrington R. E. Architectural accommodation in the complex of four p53 DNA binding domain peptides with the p21/waf1/cip1 DNA response element. J. Biol. Chem. 272:1997;14830-14841.
38. Nei M. Molecular Evolutionary Genetics. 1987;Columbia Univ. Press, New York.
39. Nowak R. Mining treasures from 'junk DNA.'. Science. 263:1994;608-610.
40. Oren M. Lonely no more: p53 finds its kin in a tumor suppressor haven. Cell. 90:1997;829-832.
41. Pesole G., Liuni S., Grillo G., Saccone C. UTRdb: A specialized database of 5′- and 3′-untranslated regions of eukaryotic mRNAs. Nucleic Acids Res. 26:1998;192-195.
42. Ren R., Mayer B. J., Cicchetti P., Baltimore D. Identification of a ten-amino acid proline-rich SH3 binding site. Science. 259:1993;1157-1161.
43. Rost B., Sander C., Schneider R. PHD - An automatic mail server for protein secondary structure prediction. Comput. Appl. Biosci. 10:1994;53-60.
44. Ruaro E. M., Collavin L., Del Sal G., Haffner R., Oren M., Levine A. J., Schneider C. A proline-rich motif in p53 is required for transactivation-independent growth arrest as induced by Gas1. Proc. Natl. Acad. Sci. USA. 94:1997;4675-4680.
45. Saccone C., Lanave C., Pesole G., Preparata G. Influence of base composition on quantitative estimates of gene evolution. Methods Enzymol. 183:1990;570-583.
46. Sanchez C., Diaz-Nido J., Avila J. Variations in in vivo phosphorylation at the proline-rich domain of the microtubule-associated protein 2 (MAP2) during rat brain development. Biochem. J. 306:1995;481-487.
47. Schmale H., Bamberger C. A novel protein with strong homology to the tumor suppressor p53. Oncogene. 15:1997;1363-1367.
48. Schmid P., Lorenz A., Hameister H., Montenarh M. Expression of p53 during mouse embryogenesis. Development. 113:1991;857-865.
49. Scolnick D. M., Chehab N. H., Stavridi E. S., Lien M. C., Caruso L., Moran E., Berger S. L., Halazonetis T. D. CREB-binding protein and p300/CBP-associated factor are transcriptional coactivators of the p53 tumor suppressor protein. Cancer Res. 57:1997;3693-3696.
50. Selivanova G., Iotsova V., Okan I., Fritsche M., Strom M., Groner B., Grafstrom R. C., Wiman K. G. Restoration of the growth suppression function of mutant p53 by a synthetic peptide derived from the p53 C-terminal domain. Nat. Med. 3:1997;632-638.
51. Shaulsky G., Goldfinger N., Ben-Ze'ev A., Rotter V. Nuclear accumulation of p53 protein is mediated by several nuclear localization signals and plays a role in tumorigenesis. Mol. Cell. Biol. 10:1990;6565-6577.
52. Sheets M. D., Fox C. A., Hunt T., Vande Woude G., Wickens M. The 3′-untranslated regions of c-mos and cyclin mRNAs stimulate translation by regulating cytoplasmic polyadenylation. Genes. Dev. 8:1994;926-938.
53. Smit A. F., Riggs A. D. MIRs are classic, tRNA-derived SINEs that amplified before the mammalian radiation. Nucleic Acids Res. 23:1995;98-102.
54. Soussi T., May P. Structural aspects of the p53 protein in relation to gene evolution: A second look. J. Mol. Biol. 260:1996;623-637.
55. Sparks A. B., Rider J. E., Hoffman N. G., Fowlkes D. M., Quillam L. A., Kay B. K. Distinct ligand preferences of Src homology 3 domains from Src, Yes, Abl, Cortactin, p53bp2, PLCgamma, Crk, and Grb2. Proc. Natl. Acad. Sci. USA. 93:1996;1540-1544.
56. Stebbins-Boaz B., Hake L. E., Richter J. D. CPEB controls the cytoplasmic polyadenylation of cyclin, Cdk2 and c-mos mRNAs and is necessary for oocyte maturation in Xenopus. EMBO J. 15:1996;2582-2592.
57. Storey A., Thomas M., Kalita A., Harwood C., Gardiol D., Mantovani F., Breuer J., Leigh I. M., Matlashewski G., Banks L. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature. 393:1998;229-234.
58. Sun X., Shimizu H., Yamamoto K. Identification of a novel p53 promoter element involved in genotoxic stress-inducible p53 gene expression. Mol. Cell. Biol. 15:1995;4489-4496.
59. Tuck S. P., Crawford L. Characterization of the human p53 gene promoter. Mol. Cell. Biol. 9:1989;2163-2172.
60. Vassalli J. D., Stutz A. Translational control. Awakening dormant mRNAs. Curr. Biol. 5:1995;476-479.
61. Verrotti A. C., Thompson S. R., Wreden C., Strickland S., Wickens M. Evolutionary conservation of sequence elements controlling cytoplasmic polyadenylylation. Proc. Natl. Acad. Sci. USA. 93:1996;9027-9032.
62. Walker K. K., Levine A. J. Identification of a novel p53 functional domain that is necessary for efficient growth suppression. Proc. Natl. Acad. Sci. USA. 93:1996;15335-15340.
63. Weiler M. C., Smith J. L., Masters J. N. CR16, a novel proline-rich protein expressed in rat brain neurons, binds to SH3 domains and is a MAP kinase substrate. J. Mol. Neurosci. 7:1996;203-215.
64. Wickens M., Anderson P., Jackson R. J. Life and death in the cytoplasm: Messages from the 3′ end. Curr. Opin. Genet. Dev. 7:1997;220-232.
65. Williamson M. P. The structure and function of proline-rich regions in proteins. Biochem. J. 297:1994;249-260.